22.08.2017 16:10:00

Diplomat to Participate in Upcoming Investor Conferences

FLINT, Mich., Aug. 22, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced that Phil Hagerman, CEO and chairman, and Atul Kavthekar, CFO, will present at the two upcoming investor conferences.

  • Wells Fargo 2017 Healthcare Conference in Boston, MA on Wednesday, Sept. 6, 2017 at 1:50 p.m. ET. A live audio-only webcast of the presentation and related presentation materials will be available on the investor relations section of the Company's website at ir.diplomat.is. The archived webcast and presentation materials will also be available for approximately 90 days following the presentation at the same URL.
  • Morgan Stanley 15th Annual Global Healthcare Conference in New York City on Wednesday, Sept. 13, 2017 at 11:40 a.m. ET.

Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.)

About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit diplomat.is.

INVESTOR CONTACT:
Bob East, Westwicke Partners
443.213.0500 | diplomat@westwicke.com

MEDIA CONTACT:
Jenny Cretu, Diplomat
810.768.9370 | jcretu@diplomat.is

View original content with multimedia:http://www.prnewswire.com/news-releases/diplomat-to-participate-in-upcoming-investor-conferences-300507255.html

SOURCE Diplomat Pharmacy, Inc.

Nachrichten zu Diplomat Pharmacy Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Diplomat Pharmacy Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!